GO
Loading...

Enter multiple symbols separated by commas

Innovation Science

More

  • Trouble with experimental treatments Wednesday, 6 Aug 2014 | 2:25 PM ET
    Trouble with experimental treatments

    Tom Geisbert, University of Texas Medical Branch, shares concerns for experimental treatments for the Ebola virus.

  • Ebola & the business of vaccines Tuesday, 5 Aug 2014 | 3:18 PM ET
    Ebola & the business of vaccines

    Darria Long Gillespie, Emory University Hospital emergency physician, discusses at what point companies will begin to invest in vaccines to treat rare diseases like Ebola.

  • Global response to Ebola Tuesday, 5 Aug 2014 | 3:16 PM ET
    Global response to Ebola

    CNBC's Eamon Javers reports two American aid workers infected with Ebola are being treated at Emory Hospital in Atlanta today and the U.S. Centers for Disease Control and Prevention is sending 50 additional experts to Africa.

  • Enormous hype about Ebola: Doctor Tuesday, 5 Aug 2014 | 2:17 PM ET
    Members of Doctors Without Borders (MSF) put on protective gear at the isolation ward of the Donka Hospital, on July 23, 2014 in Conakry.

    Breaking down the realistic threat of Ebola, and whether hospitals are prepared, with Dr. Peter Hotez, M.D. of Baylor College of Medicine.

  • Risk & compassionate use drug requests Tuesday, 5 Aug 2014 | 1:30 PM ET
    Risk & compassionate use drug requests

    Compassionate use is a way for companies to provide experimental drugs outside of clinical trials for patients with no other options. CNBC's Meg Tirrell reports on the risks for patients and drug makers.

  • Ebola patient Writebol arrives in Atlanta Tuesday, 5 Aug 2014 | 1:19 PM ET
    Ebola patient Writebol arrives in Atlanta

    The second American with Ebola has arrived in Atlanta, reports CNBC's Sue Herera.

  • Germ-zapping robot on 'Power Lunch' Tuesday, 5 Aug 2014 | 1:19 PM ET
    Germ-zapping robot on 'Power Lunch'

    Xenex Disinfection Services hopes to fight the war against Ebola. Its CEO Morris Miller shares a demonstration of the company's disinfection robot Sara, which he claims can destroy a deadly virus in 5-10 minutes.

  • Battle for experimental drugs Tuesday, 5 Aug 2014 | 11:26 AM ET
    Battle for experimental drugs

    CNBC's Meg Tirrell explains how patients with serious diseases, who have exhausted hope from medicines on the market, turn to compassionate use campaigns.

  • Ebola patient Writebol expected in Atlanta today Tuesday, 5 Aug 2014 | 10:09 AM ET
    NY tests possible Ebola victim

    NBC's Jay Gray reports Ebola patient Nancy Writebol will arrive at Emory Hospital in Atlanta today.

  • Battling a rare cancer: Nathalie's story Tuesday, 5 Aug 2014 | 7:30 AM ET
    Battling a rare cancer: Nathalie's story

    Nathalie Traller, a 15-year-old cancer patient, talks about the challenges of getting access to experimental treatments for a rare form of the disease.

  • Treating Nathalie Traller's cancer Tuesday, 5 Aug 2014 | 7:30 AM ET
    Treating Nathalie Traller's cancer

    Nathalie Traller has a rare cancer, but at 15 years old, it's been difficult to get access to treatments.

  • NYC hospital testing ill patient after Africa trip Monday, 4 Aug 2014 | 4:12 PM ET
    NYC hospital testing patient for Ebola

    CNBC's Bertha Coombs reports a patient with a high fever and gastrointestinal symptoms is undergoing screenings to determine cause of symptoms at Mt. Sinai hospital.

  • The Ebola threat Monday, 4 Aug 2014 | 2:01 PM ET
    Gloves and boots used by medical staff drying in the sun at a center for Ebola victims in Guinea.

    Ebola is now in 4 countries. NBC News' Sarah Daloff reports Emory Hospital in Atlanta, Georgia, is preparing for the arrival of the second Ebola patient Nancy Writebol.

  • Bionic eyes to supercomputers: Inside Livermore Thursday, 31 Jul 2014 | 4:32 PM ET
    Jeff Wisoff in front of the world’s largest laser at the Lawrence Livermore National Laboratory.

    Lawrence Livermore is reaching out to private industry amid a race for talent and ideas to solve pressing issues including national security.

  • AIDS researchers reported on MH17 Friday, 18 Jul 2014 | 1:23 PM ET
    AIDS researchers reported on MH17

    Reports say there could have been 100 AIDS researchers and advocates on the Malaysia Airlines flight which was shot down in Ukraine, with CNBC's Meg Tirrell.

  • Close look at traders' brain activity Friday, 11 Jul 2014 | 2:41 PM ET
    Close look at traders' brain activity

    Neuroscientist Read Montague performed a study of traders' brain activity while trading. He shares which traders made the most money in the experiment.

  • Climate skeptics look to prove their skeptics wrong Monday, 7 Jul 2014 | 8:00 AM ET
    Mana Pools National Park. Zimbabwe

    Climate change skeptic group The Heartland Institute hosts its annual conference this week and hopes to take on President Obama and others.

  • Cool pharma tech Tuesday, 10 Jun 2014 | 5:27 PM ET
    Cool pharma tech

    CNBC's Meg Tirrell reports which pharmaceutical stocks are ready for the future of medicine, including Covidien's swallowable pill-size camera.

  • Rethinking health care Tuesday, 10 Jun 2014 | 2:53 PM ET
    Rethinking health care

    Why does the U.S. spend so much money on health care? Daniel Kraft, Exponential Medicine executive director, says the U.S. spends a lot of money on "sick" care, not health care, and provides insight to new technology developments in the industry.

  • Immunotherapies hit ASCO Thursday, 29 May 2014 | 3:35 PM ET
    Immunotherapies hit ASCO

    This year's biggest cancer conference begins tomorrow. CNBC's Meg Tirrell reports why immunotherapy drugs will be a key theme with drug makers at ASCO.